NIH #R01CA262425
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
Expiring Soon
- Amount
- $600K–$700K
- Period
- 2021-09-16 → 2026-08-31
- PIs
- 2
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR